A detailed history of Lindbrook Capital, LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Lindbrook Capital, LLC holds 365 shares of IONS stock, worth $13,866. This represents 0.0% of its overall portfolio holdings.

Number of Shares
365
Previous 389 6.17%
Holding current value
$13,866
Previous $18,000 22.22%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$40.06 - $51.86 $961 - $1,244
-24 Reduced 6.17%
365 $14,000
Q2 2024

Jul 31, 2024

BUY
$36.45 - $47.7 $2,733 - $3,577
75 Added 23.89%
389 $18,000
Q1 2024

Apr 25, 2024

SELL
$42.03 - $53.55 $3,320 - $4,230
-79 Reduced 20.1%
314 $13,000
Q4 2023

Jan 31, 2024

BUY
$43.39 - $51.63 $3,688 - $4,388
85 Added 27.6%
393 $19,000
Q3 2023

Oct 25, 2023

SELL
$38.5 - $47.13 $1,463 - $1,790
-38 Reduced 10.98%
308 $13,000
Q2 2023

Jul 28, 2023

BUY
$34.73 - $43.33 $3,681 - $4,592
106 Added 44.17%
346 $14,000
Q1 2023

Apr 26, 2023

BUY
$33.58 - $41.2 $4,197 - $5,150
125 Added 108.7%
240 $8,000
Q4 2022

Jan 24, 2023

SELL
$37.12 - $46.52 $2,524 - $3,163
-68 Reduced 37.16%
115 $0
Q3 2022

Nov 10, 2022

BUY
$36.54 - $48.66 $4,604 - $6,131
126 Added 221.05%
183 $8,000
Q1 2022

Apr 21, 2022

BUY
$29.88 - $37.04 $1,105 - $1,370
37 Added 185.0%
57 $2,000
Q4 2021

Jan 18, 2022

SELL
$25.61 - $35.1 $2,100 - $2,878
-82 Reduced 80.39%
20 $1,000
Q3 2021

Nov 05, 2021

BUY
$33.54 - $40.55 $2,884 - $3,487
86 Added 537.5%
102 $3,000
Q2 2021

Jul 27, 2021

SELL
$34.54 - $47.25 $1,036 - $1,417
-30 Reduced 65.22%
16 $1,000
Q4 2020

Jan 27, 2021

BUY
$45.3 - $60.27 $2,083 - $2,772
46 New
46 $3,000
Q3 2020

Nov 03, 2020

SELL
$47.45 - $62.95 $949 - $1,259
-20 Closed
0 $0
Q1 2020

Apr 22, 2020

BUY
$41.6 - $63.4 $832 - $1,268
20 New
20 $1,000
Q3 2019

Oct 31, 2019

SELL
$59.06 - $72.15 $2,598 - $3,174
-44 Closed
0 $0
Q4 2018

Feb 07, 2019

BUY
$43.37 - $59.54 $1,908 - $2,619
44 New
44 $2,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.39B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.